HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Rett syndrome: retrospective and prospective study of 28 patients].

Abstract
From November 1982 to May 1999, 28 children with Rett syndrome were followed-up for a medium period of 6 years and 2 months. Regression of developmental milestones started at the age between 5 and 20 months. Nineteen cases of typical Rett syndrome had uneventful pre and perinatal periods, loss of previously acquired purposeful hand skills, mental and motor regression and developed hand stereotypies; sixteen had head growth deceleration and 12 gait apraxia. Nine patients were atypical cases, 2 formes frustres, 2 congenital, 3 with early seizure onset, 1 preserved speech and 1 male. Epilepsy was present in 21 patients, predominantly partial seizures and the drug of choice was carbamazepine (15 patients). In the initial evaluation most patients were distributed on Stages II and III and on follow-up on Stages III and IV. Three children died.
AuthorsI Bruck, S A Antoniuk, S M Halick, A Spessatto, L R Bruyn, M Rodrigues, J Koneski, D Facchim
JournalArquivos de neuro-psiquiatria (Arq Neuropsiquiatr) Vol. 59 Issue 2-B Pg. 407-10 (Jun 2001) ISSN: 0004-282X [Print] Germany
Vernacular TitleSíndrome de Rett: estudo retrospectivo e prospectivo de 28 pacientes.
PMID11460188 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Anticonvulsants
  • Carbamazepine
Topics
  • Adolescent
  • Adult
  • Anticonvulsants (therapeutic use)
  • Carbamazepine (therapeutic use)
  • Child
  • Child, Preschool
  • Epilepsy (diagnosis, drug therapy)
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Male
  • Prospective Studies
  • Retrospective Studies
  • Rett Syndrome (classification, diagnosis, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: